Cloricromen (Cloricromene) is an orally active platelet inhibitor. Cloricromen inhibits thromboxane B 2 release, β-thromboglobulin , and thrombus formation. Cloricromen inhibits LPS ( HY-D1056 )-induced NF-κB activation, oxidative activity, and TNF-α expression. Cloricromen exhibits protective activity in animal models of shock and peripheral ischaemia. Cloricromen can be used for the research of myocardial ischaemia/reperfusion injury, and ischaemic cerebrovascular disease.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > NF-κB | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > TNF Receptor | Products > Signaling Pathways > NF-κB
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.